AVITA Medical, Inc. Accrued Investment Income Receivable
AVITA Medical, Inc. (RCEL) had Accrued Investment Income Receivable of $212.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Balance Sheet › Assets
us-gaap:AccruedInvestmentIncomeReceivable · last filed 2024-08-08
- 2024-06-30: Accrued Investment Income Receivable $212.00K.
- 2024-03-31: Accrued Investment Income Receivable $182.00K.
- 2023-12-31: Accrued Investment Income Receivable $227.00K.
- 2023-09-30: Accrued Investment Income Receivable $228.00K.
| Period end | Accrued Investment Income Receivable |
|---|---|
| 2024-06-30 | $212.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $182.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $227.00K 10-Q · filed 2024-08-08 |
| 2023-09-30 | $228.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $168.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $134.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $168.00K 10-K · filed 2024-02-22 |
| 2022-09-30 | $146.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $136.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $123.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $72.00K 10-K · filed 2023-02-23 |
| 2021-09-30 | $59.00K 10-Q · filed 2021-11-08 |